Commentary: What is the measure of success for atrial fibrillation ablation? Is a reduction in arrhythmia burden sufficient?
- PMID: 33965223
- PMCID: PMC9680864
- DOI: 10.1016/j.jtcvs.2021.04.015
Commentary: What is the measure of success for atrial fibrillation ablation? Is a reduction in arrhythmia burden sufficient?
Figures
Comment on
-
Thoracoscopic ablation delays progression from paroxysmal to persistent atrial fibrillation.J Thorac Cardiovasc Surg. 2023 Apr;165(4):1387-1394. doi: 10.1016/j.jtcvs.2021.03.114. Epub 2021 Apr 19. J Thorac Cardiovasc Surg. 2023. PMID: 33992460
References
-
- Li X, Li1 M, Shao Y, Gu W, Ni B, Gu J, Chen M. Thoracoscopic ablation delays progression from paroxysmal to persistent atrial fibrillation. J Thorac Cardiovasc Surg 2021: in press. - PubMed
-
- Olesen JB, Lip GY, Lindhardsen J, et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study. Thromb Haemost 2011;106:739–49. - PubMed
-
- Friberg L, Rosenqvist M, Lip GY. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation 2012;125:2298–30. - PubMed
-
- January C, Wann L, Alpert J, Calkins H, Chen L, Cigarroa J, et al. 014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014. Dec, 64 (21) 2246–2280. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
